Literature DB >> 19917915

A case-control study of smoking and bladder cancer risk: emergent patterns over time.

Dalsu Baris1, Margaret R Karagas, Castine Verrill, Alison Johnson, Angeline S Andrew, Carmen J Marsit, Molly Schwenn, Joanne S Colt, Sai Cherala, Claudine Samanic, Richard Waddell, Kenneth P Cantor, Alan Schned, Nathaniel Rothman, Jay Lubin, Joseph F Fraumeni, Robert N Hoover, Karl T Kelsey, Debra T Silverman.   

Abstract

BACKGROUND: Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear.
METHODS: We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects).
RESULTS: Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity.
CONCLUSIONS: Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.

Entities:  

Mesh:

Year:  2009        PMID: 19917915      PMCID: PMC2778671          DOI: 10.1093/jnci/djp361

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  42 in total

1.  Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies.

Authors:  P Brennan; O Bogillot; S Cordier; E Greiser; W Schill; P Vineis; G Lopez-Abente; A Tzonou; J Chang-Claude; U Bolm-Audorff; K H Jöckel; F Donato; C Serra; J Wahrendorf; M Hours; A T'Mannetje; M Kogevinas; P Boffetta
Journal:  Int J Cancer       Date:  2000-04-15       Impact factor: 7.396

Review 2.  The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder.

Authors:  D Hoffmann; I Hoffmann; K El-Bayoumy
Journal:  Chem Res Toxicol       Date:  2001-07       Impact factor: 3.739

3.  Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.

Authors:  P Vineis; D Marinelli; H Autrup; J Brockmoller; I Cascorbi; A K Daly; K Golka; H Okkels; A Risch; N Rothman; E Sim; E Taioli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-12       Impact factor: 4.254

4.  Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type.

Authors:  Ahmedin Jemal; William D Travis; Robert E Tarone; Lois Travis; Susan S Devesa
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

Review 5.  Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation.

Authors:  P Vineis; M Kogevinas; L Simonato; P Brennan; P Boffetta
Journal:  Mutat Res       Date:  2000-07       Impact factor: 2.433

6.  Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking.

Authors:  S D Stellman; J E Muscat; S Thompson; D Hoffmann; E L Wynder
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

7.  A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).

Authors:  Maurice P A Zeegers; R Alexandra Goldbohm; Piet A van den Brandt
Journal:  Cancer Causes Control       Date:  2002-02       Impact factor: 2.506

8.  Gender- and smoking-related bladder cancer risk.

Authors:  J E Castelao; J M Yuan; P L Skipper; S R Tannenbaum; M Gago-Dominguez; J S Crowder; R K Ross; M C Yu
Journal:  J Natl Cancer Inst       Date:  2001-04-04       Impact factor: 13.506

9.  Nonsmoking-related arylamine exposure and bladder cancer risk.

Authors:  Paul L Skipper; Steven R Tannenbaum; Ronald K Ross; Mimi C Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-06       Impact factor: 4.254

10.  Cigarette smoking and cancer: intensity patterns in the alpha-tocopherol, beta-carotene cancer prevention study in Finnish men.

Authors:  Jay H Lubin; Jarmo Virtamo; Stephanie J Weinstein; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2008-02-03       Impact factor: 4.897

View more
  72 in total

1.  Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.

Authors:  Alan R Schned; Petra Lenz; Lee E Moore; Alison Johnson; Michael Jones; Masatoshi Kida; Debra T Silverman; Molly Schwenn; Karl T Kelsey; Angeline S Andrew; Dalsu Baris; Margaret R Karagas
Journal:  ISRN Pathol       Date:  2012

2.  GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

Authors:  L E Moore; D R Baris; J D Figueroa; M Garcia-Closas; M R Karagas; M R Schwenn; A T Johnson; J H Lubin; D W Hein; C L Dagnall; J S Colt; M Kida; M A Jones; A R Schned; S S Cherala; S J Chanock; K P Cantor; D T Silverman; N Rothman
Journal:  Carcinogenesis       Date:  2010-10-29       Impact factor: 4.944

3.  Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples.

Authors:  Dana van Bemmel; Petra Lenz; Linda M Liao; Dalsu Baris; Lawrence R Sternberg; Andrew Warner; Alison Johnson; Michael Jones; Masatoshi Kida; Molly Schwenn; Alan R Schned; Debra T Silverman; Nathaniel Rothman; Lee E Moore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-04-26       Impact factor: 4.254

4.  Association between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: a case-control study.

Authors:  Jing-Hua Ren; Min Jin; Wen-Shan He; Cui-Wei Liu; Shun Jiang; Wei-Hong Chen; Kun-Yu Yang; Gang Wu; Tao Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

5.  Cigarette smoking and bladder cancer: a new twist in an old saga?

Authors:  Anthony J Alberg; James R Hébert
Journal:  J Natl Cancer Inst       Date:  2010-01-20       Impact factor: 13.506

6.  Cigarette smoking and bladder cancer: a new twist in an old saga?

Authors:  Anthony J Alberg; James R Hébert
Journal:  J Natl Cancer Inst       Date:  2009-11-16       Impact factor: 13.506

7.  Developing estimates of frequency and intensity of exposure to three types of metalworking fluids in a population-based case-control study of bladder cancer.

Authors:  Melissa C Friesen; Dong-Uk Park; Joanne S Colt; Dalsu Baris; Molly Schwenn; Margaret R Karagas; Karla R Armenti; Alison Johnson; Debra T Silverman; Patricia A Stewart
Journal:  Am J Ind Med       Date:  2014-08       Impact factor: 2.214

8.  EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT.

Authors:  Elizabeth A Handorf; Justin E Bekelman; Daniel F Heitjan; Nandita Mitra
Journal:  Ann Appl Stat       Date:  2013       Impact factor: 2.083

9.  Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.

Authors:  Montserrat Garcia-Closas; Nathaniel Rothman; Jonine D Figueroa; Ludmila Prokunina-Olsson; Summer S Han; Dalsu Baris; Eric J Jacobs; Nuria Malats; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Sapna Sharma; Yi-Ping Fu; Manolis Kogevinas; Zhaoming Wang; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Susan M Gapstur; Michael Thun; William Ryan Diver; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Amy Hutchinson; Laurie Burdett; Kevin B Jacobs; Meredith Yeager; Joseph F Fraumeni; Stephen J Chanock; Debra T Silverman; Nilanjan Chatterjee
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

Review 10.  Environmental non-occupational risk factors associated with bladder cancer.

Authors:  J Ferrís; O Berbel; J Alonso-López; J Garcia; J A Ortega
Journal:  Actas Urol Esp       Date:  2013-04-22       Impact factor: 0.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.